Altamira Therapeutics Ltd.: xbrl:AdjustedWeightedAverageShares

Value{"unit": "shares", "value": 1080502}
Period2021-01-01 – 2021-06-30
Statussuperseded
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-21-046965
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/ad74c228-e3c1-4db8-b3d5-7797b149ecd1

History